Lv1
80 积分 2023-09-17 加入
Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges
2天前
已完结
Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure
25天前
已完结
Global epidemiology of heart failure
25天前
已完结
Defining an epigenetic code
2个月前
已完结
The role of demethylases in cardiac development and disease
4个月前
已完结
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
6个月前
已完结
Histone post-translational modifications — cause and consequence of genome function
10个月前
已完结
Heart failure and kidney dysfunction: epidemiology, mechanisms and management
1年前
已完结
Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans
1年前
已完结
Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial
1年前
已关闭
皖公网安备34019202002308
